Impact of antiviral therapy on short‐ and long‐term outcomes of patients with chronic obstructive pulmonary disease after influenza infection
Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola A Hanania · 2023
Read Impact of antiviral therapy on short‐ and long‐term outcomes of patients with chronic obstructive pulmonary disease after influenza infection by Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola A Hanania (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10719080.txt.
Description
Christopher Wallick and co-authors measure the payoff of fast antiviral treatment when flu hits lung disease patients, in a 2023 study. The patients have chronic obstructive pulmonary disease. Flu often triggers dangerous flare-ups in them. The team used insurance claims across five flu seasons. Patients treated within two days of diagnosis were matched to untreated peers. Over four thousand treated patients were included. Care use and costs were tracked for over a year.
Treated patients flared less in the first month. The gap persisted across the following year. Hospital stays for lung and pneumonia causes fell sharply. Emergency and clinic visits also dropped. Costs followed the same pattern, with one small exception. Pneumonia outcomes favored treatment at every window. The authors argue speed matters in this group. Early antivirals, they say, pay for themselves. The study is retrospective, so matching carried the causal weight.
Catalog record
| CREATOR | Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola A Hanania |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |